| BRCA1 and BRCA2 mutations and treatment strategies for breast cancer I Godet, DM Gilkes Integrative cancer science and therapeutics 4 (1), 2017 | 236 | 2017 |
| Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis I Godet, YJ Shin, JA Ju, IC Ye, G Wang, DM Gilkes Nature communications 10 (1), 4862, 2019 | 161 | 2019 |
| Hypoxia Selectively Enhances Integrin α5β1 Receptor Expression in Breast Cancer to Promote Metastasis JA Ju, I Godet, IC Ye, J Byun, H Jayatilaka, SJ Lee, L Xiang, D Samanta, ... Molecular Cancer Research 15 (6), 723-734, 2017 | 119 | 2017 |
| Extracellular fluid viscosity enhances cell migration and cancer dissemination K Bera, A Kiepas, I Godet, Y Li, P Mehta, B Ifemembi, CD Paul, A Sen, ... Nature 611 (7935), 365-373, 2022 | 106 | 2022 |
| Molecular portrait of hypoxia in breast cancer: a prognostic signature and novel HIF-regulated genes IC Ye, EJ Fertig, JW DiGiacomo, M Considine, I Godet, DM Gilkes Molecular Cancer Research 16 (12), 1889-1901, 2018 | 85 | 2018 |
| Collective cancer cell invasion induced by coordinated contractile stresses AMJ Valencia, PH Wu, ON Yogurtcu, P Rao, J DiGiacomo, I Godet, L He, ... Oncotarget 6 (41), 43438, 2015 | 79 | 2015 |
| Detection of hypoxia in cancer models: significance, challenges, and advances I Godet, S Doctorman, F Wu, DM Gilkes Cells 11 (4), 686, 2022 | 55 | 2022 |
| Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis R Wang, I Godet, Y Yang, S Salman, H Lu, Y Lyu, Q Zuo, Y Wang, Y Zhu, ... Proceedings of the National Academy of Sciences 118 (19), e2020490118, 2021 | 48 | 2021 |
| A persistent invasive phenotype in post-hypoxic tumor cells is revealed by fate mapping and computational modeling HL Rocha, I Godet, F Kurtoglu, J Metzcar, K Konstantinopoulos, S Bhoyar, ... Iscience 24 (9), 2021 | 24 | 2021 |
| RhoB is regulated by hypoxia and modulates metastasis in breast cancer JA Ju, I Godet, JW DiGiacomo, DM Gilkes Cancer Reports 3 (1), e1164, 2020 | 22 | 2020 |
| Post-hypoxic cells promote metastatic recurrence after chemotherapy treatment in TNBC I Godet, M Mamo, A Thurnheer, DM Rosen, DM Gilkes Cancers 13 (21), 5509, 2021 | 17 | 2021 |
| Extracellular matrix–bound fgf2 mediates estrogen receptor signaling and therapeutic response in breast cancer JW DiGiacomo, I Godet, M Trautmann-Rodriguez, DM Gilkes Molecular Cancer Research 19 (1), 136-149, 2021 | 17 | 2021 |
| BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 2017; 4 (1) I Godet, DM Gilkes | 16 | |
| Digitize your Biology! Modeling multicellular systems through interpretable cell behavior JAI Johnson, GL Stein-O’Brien, M Booth, R Heiland, F Kurtoglu, ... bioRxiv, 2023 | 5 | 2023 |
| Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness NS Joe, I Godet, N Milki, NUI Ain, HH Oza, GJ Riggins, DM Gilkes Breast Cancer Research 24 (1), 98, 2022 | 5 | 2022 |
| A software tool for the quantification of metastatic colony growth dynamics and size distributions in vitro and in vivo S Bhoyar, I Godet, JW DiGiacomo, DM Gilkes PloS one 13 (12), e0209591, 2018 | 5 | 2018 |
| BRCA1 and BRCA2 mutations and treatment strategies for breast cancer, 344 (6188), 1173–1178 I Godet, DM Gilkes | 5 | 2017 |
| Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells NS Joe, Y Wang, HH Oza, I Godet, N Milki, GJ Riggins, DM Gilkes Cancers 15 (4), 1330, 2023 | 3 | 2023 |
| The rise of viperin: the emerging role of viperin in cancer progression AG Weinstein, I Godet, DM Gilkes The Journal of Clinical Investigation 132 (24), 2022 | 3 | 2022 |
| Valsartan and sacubitril combination treatment enhances collagen production in older adult human skin cells S Marin, I Godet, LS Nidadavolu, J Tian, LE Dickinson, JD Walston, ... Experimental gerontology 165, 111835, 2022 | 3 | 2022 |
Daniele M GilkesJohns Hopkins University School of MedicineVerified email at jhu.edu
